Vanguard Group’s Unicycive Therapeutics UNCY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.89M | Sell |
605,953
-606,488
| -50% | -$2.89M | ﹤0.01% | 3400 |
|
2025
Q1 | $697K | Buy |
1,212,441
+74,221
| +7% | +$42.7K | ﹤0.01% | 3810 |
|
2024
Q4 | $904K | Hold |
1,138,220
| – | – | ﹤0.01% | 3794 |
|
2024
Q3 | $464K | Hold |
1,138,220
| – | – | ﹤0.01% | 3989 |
|
2024
Q2 | $570K | Buy |
1,138,220
+798,360
| +235% | +$400K | ﹤0.01% | 3957 |
|
2024
Q1 | $469K | Buy |
339,860
+224,803
| +195% | +$310K | ﹤0.01% | 4029 |
|
2023
Q4 | $99.8K | Hold |
115,057
| – | – | ﹤0.01% | 4301 |
|
2023
Q3 | $98.9K | Hold |
115,057
| – | – | ﹤0.01% | 4352 |
|
2023
Q2 | $147K | Hold |
115,057
| – | – | ﹤0.01% | 4353 |
|
2023
Q1 | $242K | Buy |
115,057
+92,362
| +407% | +$194K | ﹤0.01% | 4294 |
|
2022
Q4 | $12.3K | Hold |
22,695
| – | – | ﹤0.01% | 4505 |
|
2022
Q3 | $13K | Hold |
22,695
| – | – | ﹤0.01% | 4597 |
|
2022
Q2 | $19K | Hold |
22,695
| – | – | ﹤0.01% | 4614 |
|
2022
Q1 | $29K | Hold |
22,695
| – | – | ﹤0.01% | 4623 |
|
2021
Q4 | $47K | Buy |
+22,695
| New | +$47K | ﹤0.01% | 4628 |
|